Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Released Nov 13, 2018, after the close
10-Q filed Nov 13, 2018, 44 days after period end · 0001144204-18-059353
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $0.00 | $183.06K | — | — |
| Net Income | -$4.39M | -$3.99M | -$2.10M | $28.50M |
| EPS Diluted | -$0.32 | -$0.39 |
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
| -$0.29 |
| $4.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
